19.2. Genetic technology applied to medicine
A subsection of Biology, 9700, through 19. Genetic technology
Listing 10 of 37 questions
9700_w08_qp_4
THEORY
2008
Paper 4, Variant 0
Severe combined immunodeficiency (SCID) is a group of life-threatening diseases. SCID is caused by mutations that prevent the normal function of the immune system. Infants born with SCID are at very high risk of infectious diseases. One feature of SCID is that T-lymphocytes do not develop normally. In the development of normal T-lymphocytes, the production of circular pieces of DNA called T-lymphocyte receptor excision circles (TRECs) is an important event. It is possible to use the polymerase chain reaction (PCR) to detect TRECs in DNA extracted from a sample of blood. The results of this reaction can be used to identify children with SCID. Describe the role of the primers in the PCR used for the detection of TRECs. Suggest and explain how the results of PCR for the detection of TRECs can be used to identify children with SCID. Before 2010, children in the United States of America (USA) were tested for SCID either: • if someone in their family history had SCID, or • if they developed several infections in a short space of time. From 2010, the USA started to introduce a screening programme for SCID, in which children were tested soon after birth. By 2016, the screening programme was used for nearly all children in the USA. shows the percentage contribution of each of these three approaches to the identification of children with SCID from 2010 to 2016 in the USA. percentage contribution to the identification of children with SCID 2010 2011 2012 2013 year 2014 2015 2016 key family history infections screening programme With reference to , describe how the contribution of the three approaches to the identification of children with SCID changed from 2010 to 2016. Suggest the advantages of screening all children for SCID soon after birth. One form of SCID is caused by a mutation that results in a deficiency of the enzyme adenosine deaminase (ADA). Children with ADA-deficient SCID can be treated with gene therapy using a virus. After successful gene therapy, the children are able to produce ADA for themselves. Suggest how children with ADA-deficient SCID can be treated with gene therapy using a virus. Outline the challenges of using a virus for gene therapy.
9700_m20_qp_42
THEORY
2020
Paper 4, Variant 2
Questions Discovered
37